Newsletter | August 5, 2025

Best of July 2025: Top 5 Insights In Drug Formulation & Delivery

Drug Delivery Leader

TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY 

JULY EDITION

#1 - Drug Delivery Innovation: If You Build It, Will Anyone Care?

In this article, Fran DeGrazio explains why innovation in drug delivery technologies may not need to be revolutionary, but will no doubt need patient adoption, payor support, and regulatory follow-on to become sticky in the marketplace.

#2 - Treating Chronic Conditions Via Long-Acting Implants With Vivani's Adam Mendelsohn

In this episode of Sit and Deliver, host Tom von Gunden talks with CEO Adam Mendelsohn of Vivani Medical about enhancing patient adherence and convenience via long-acting, controlled release implants delivering medications for chronic conditions.

#3 - Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet

This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.

#4 - Five Ways Pre-Filled Syringes Contribute To Better Patient Outcomes

In Curia's series on pre-filled syringes, explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

#5 - From Matrix To Medicine: New Frontiers In Treating Pulmonary Fibrosis And PH

Halo Biosciences is building a pipeline based on novel insights into how extracellular matrix dysregulation drives disease. We caught up with its leaders to discuss their approach to drug targeting and early development.